(put something here)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If you are deciding to buy this mid to high risk stock, GXGX, here is what they are.
Click on link below and listen to broadcast.
Joint Investor Conference Call – Celularity
https://celularity.com/joint-investor-conference-call/
We need Sorrento's rapid test more than ever. Cuomo wants to employ a 15 minute rapid tests which are not very accurate to open restaurants and theaters. If Henry Ji says their rapid test is over 90% effective, that will be great for Sorrento and the population.
https://www.nbcnewyork.com/news/coronavirus/gov-cuomo-pitches-rapid-testing-to-start-reopening-restaurants-and-theaters/2828266/
People should assume it's going well because JP Morgan just increased its holdings in Sorrento therapeutics.
1776club Just to be clear, I'm not attacking your comment because I know you are a Sorrento investor just like most here on the board. I just wanted to point out that regardless of what we say, do, think, accuse. Support, Sorrento will do what they do and we will get what we get. I just hope we get money and not get screwed. Hehehe
Yes. I can support my position with one simple fact. There are many institutional investors out there with way more to lose than all of us here combined. Many other institutional investors followed the popular crowd to invest in the larger corporations. But their confidence in SRNE solidifies my minuscule 11,000 shares by a long shot, so I trust in the elites who invest millions through better research than we are privy to in my opinion. Before anyone invests millions into a relatively unknown biotech with great expansion over the years as Sorrento had done, then their confidence is my confidence. Sure, you can point out all the failures and denounce any progress with your own narrative, but in the end, time will tell. Not biased rhetoric or positive sentiment.
So you are suggesting that BlackRock is not big money? With 25 million shares? So I guess that you are suggesting they are small time investors putting over 150 million dollars in junk stocks for the slim blind chance that, maybe, might, hopefully, small chance in hell, might possibly, mabey get lucky....?
Ok, I'll buy that argument. Heck, I remember when I felt lucky one time and put 40 bucks on a horse to win! How crazy is that!
The fact that they were paid does not detract from the fact that the comprehensive work on their analysis was fraudulent. They may have been paid well because they really get involved in details and the analysis's. I don't believe they are being paid to pump the stock. They could have saved so much extra work in their analysis's by making it much shorter if that were the case.
I'm no expert but, looking at the 1 month chart trend we are at the low part of the resistance level. So if the chart continues the trend it's possible we should be going up from here to the mid 8 range. Just just my opinion.
Different company. Not Sorrento. Too bad.
https://www.cnn.com/2020/12/09/health/fda-over-counter-covid-test/index.html
OMG OMG OMG OMG OMG OMG OMG!!
1776club: It was the non opioid pain medication that is the potential big money maker. That was the excitement pre-covid. Billions.
Benzinga News:
Read entire article. Sorrento is mentioned a few times within the article til the end.
https://m.benzinga.com/article/18705139
If that were the case, then the government would be quite content in what they have with Moderna and Phizer and would have the FDA discontinue EUA for any other products going forward. But that did not happen now did it? Sorrento Therapeutics did receive EAU for the warp speed program. So the game is still on. Other vaccines and Therapeutics are just competition at the moment. Plenty of opportunities out there for improvement. Sorrento is on track for getting a piece of that opportunity.
AND AWAY WE GO!!
I know! The excitement was definitely present.
Beautiful presentation. Lots of excitement from Benzinga's team. They love the way the chat board lit up on their end. Approval from FDA real soon, looks like within weeks the way it sounds, or even within days.
Prospectus filed and new 8k. Thoughts??
Very impressive.
SRNE is not a pump and dump stock. Look how DARPA came in and made a contract with Sorento therapeutics. Nothing was said leading up to this deal by Dr. Henry Ji. Going forward, lthere will not be any hints of any approvals of anything in the pipeline. It'll just appear in the news. Accumulate now while it's cheap or you can chase it up along the way.
Just need some positive results!
I'm ready!!
Awfully quiet here with the stock rising.....
Good point. I thought the same thing.
Since Elon musk said how inaccurate current testing is for Covid 19, Sorrento therapeutics can be tremendous. Need FDA approval now!
Read this [Link]: Elon Musk says covid tests aren't accurate. Great news for SRNE!!
https://nypost.com/2020/11/13/elon-musk-continues-to-cast-doubt-about-covid-19-test-results/
Yes! That makes sense. After they make the dry the ice they use a blow dryer to make it more dry.
You shouldn't have said that. Tomorrow they will have a report saying "actually, -78C is fine..... ??"
$26 Billion Settlement Offer in Opioid Lawsuits Gains Wide Support.
Article from NY Times
Doctor Henry Ji, Sorrento therapeutics and company, should get their non opioid pain killers through, hopefully easily with the FDA because of situations like this. Read on.
Three distributors and a drug manufacturer have proposed a deal that a majority of states and negotiators for small governments finally seem to like.
The McKesson Corporation, based in San Francisco, would pay $8 billion of the settlement alone. Credit...Anastasiia Sapon for The New York Times
By Jan Hoffman
Nov. 5, 2020
The three major drug distributors and a large drug manufacturer are closing in on a $26 billion deal with state and local governments that would end thousands of lawsuits over the companies’ role in the opioid epidemic, according to people close to the negotiations and new company filings.
The deal is $4 billion more than an offer made a year ago, that was rejected by many states and municipalities. A major difference in the latest offer is $2 billion earmarked for private lawyers who represent cities, counties, and some states.
If the deal is finalized, four of the most prominent defendants in the behemoth, nationwide litigation — McKesson, Cardinal Health, AmerisourceBergen and Johnson & Johnson — would no longer be at risk from future opioid lawsuits by these governments. Other drug manufacturers and the national pharmacy chains are still facing thousands of such cases.
Most of the money from the settlement deal is intended to help pay for treatment and prevention programs in communities ravaged by addiction and overdoses. From 1999 through 2018, 232,000 Americans died from overdoses of prescription opioids, according to the latest numbers from Centers for Disease Control and Prevention. Addiction to the painkillers also triggered an epidemic of abuse of illegal opioids like heroin, contributing to an avalanche of deaths, crime and soaring health care costs.
Litigation over the drug industry’s responsibility has been bitterly fought, resulting in a handful of settlements and the declaration of bankruptcy by some drug manufacturers, including Purdue Pharma, which just reached a settlement of federal criminal and civil charges.
The three distributors announced the outlines of their settlement offers in quarterly earnings reports released Tuesday and Thursday. Johnson & Johnson announced its portion in a filing last month.
The distributors shipped more than three-quarters of the nation’s opioids to pharmacies, rarely raising red flags even when quantities were wildly disproportionate to a store’s local population, according to federal data. Over 10 years, for example, the companies shipped nearly 21 million prescription painkillers to two pharmacies four blocks apart in a West Virginia town with a population of 2,900.
The latest deal is being brokered under the shadow of two major trials tentatively scheduled for January, which the companies are hoping to avoid. Unlike last year’s smaller settlement offer, which was witheringly rejected by many states but especially by lawyers negotiating for thousands of counties, cities and tribes, this offer is being widely lauded.
Awesome! EAU looks done.
I just finished listening to the Podcast of the mad money episode today with Sorento therapeutics Henry Ji. I wanted to figure out for myself why the stock plummeted. I found absolutely no reason why anyone would sell,The episode was upbeat, informative with no negative response whatsoever. Holding my shares. All 7000 of them.
Ji should stick to PR's and avoid anything live.
SRNE is progressing nicely. I'm glad they're doing a larger scale human test trial. If the end result is positive, which I'm sure it will be, up up and away!
Does anyone know any information regarding Modus saying that they have an "equity interest" with ALYI? It says it in their news release.
What does it mean that Modus has an "equity interest" with ALYI? It mentioned that it the PR.
Professor David mitlin owns the patent fir the marijuana nano sheets.
Clarkson University Professor David Mitlin on board to lead the initiative. Professor Mitlin is a leading expert in electrochemistry and a pioneer in the use of hemp as a clean, green, renewable energy in the form of a supercapacitor. Mitlin has successfully used hemp bast - the fiber left over from processing hemp - to construct carbon nanosheets that compete with, and in some respects, outperform the supercapacitor performance derived from more typical graphene nanosheets. Mitlin does hold a US patent for his proprietary hemp energy storage technology.
She also said, "Fuggetaboutit"
No offense but, I dont know if any of you who are discussing reasons why Aurora price is going down, whether shorting, market manipulation, profiteering, switching over to tech, etc, etc, etc,...have noticed, but the entire stock market, "including" cannabis stocks, has been crashing for a week now, not just Aurora Cannabis inc.